Charlier D, Gigot D, Huysveld N, Roovers M, Piérard A, Glansdorff N
Research Institute of the CERIA-COOVI, Brussels, Belgium.
J Mol Biol. 1995 Jul 21;250(4):383-91. doi: 10.1006/jmbi.1995.0384.
By measuring the protection against Dam methylase modification of a GATC sequence located 106 bp upstream of the startpoint of promoter P1 in the control region of the carAB operon (encoding carbamoylphosphate synthetase) we have obtained evidence for a direct correlation between the degree of in vivo occupancy of a specific regulatory target site and the repressibility of the P1 promoter by pyrimidine residues. A high uridine nucleotide pool as well as binding of the carP (alias xerB/pepA) gene product and of the integration host factor (IHF) to the carAB control region are prerequisites to observe this in vivo protection. Purified CarP binds in vitro to the carAB control region and protects against DNase I two approximately 25 bp long stretches, one of which is located just downstream of the GATC sequence. Mutations in this site strongly impair the pyrimidine regulation of the P1 promoter and the interference with Dam methylase modification. These processes are also strongly impaired in the absence of integration host factor and in mutants affected in the IHF site located some 200 bp upstream of this Dam methylase modification site. IHF therefore exerts at least part of its antagonistic effects on P1, i.e. increased expression in minimal medium but increased repression in the presence of pyrimidine residues, indirectly by influencing the formation or the stability of a particular protein-DNA complex. Furthermore, we demonstrate that the distance separating the IHF and Dam methylase target sites is crucial for the in vivo protection and for pyrimidine-mediated regulation of the promoter expression. Mutations altering this distance result in severe reductions of the degree of in vivo protection and, concomitantly, of the repressibility by pyrimidine residues of promoter P1 activity in a way indicative of the formation of a complex nucleoprotein structure. Since neither IHF nor CarP require pyrimidine residues to bind to the carAB control region, at least not in vitro, it is tempting to suggest that IHF and CarP-induced bending and looping provide changes in DNA topology that are required for assembling a specific pyrimidine-dependent nucleoprotein complex that modulates P1 activity.
通过测量对位于氨基甲酰磷酸合成酶编码基因carAB操纵子控制区中启动子P1起点上游106 bp处的GATC序列的Dam甲基化修饰的保护作用,我们获得了证据,证明特定调控靶位点的体内占据程度与嘧啶残基对P1启动子的抑制能力之间存在直接关联。高尿苷核苷酸池以及carP(别名xerB/pepA)基因产物和整合宿主因子(IHF)与carAB控制区的结合是观察到这种体内保护作用的先决条件。纯化的CarP在体外与carAB控制区结合,并保护两个约25 bp长的片段免受DNase I的切割,其中一个片段正好位于GATC序列的下游。该位点的突变严重损害了P1启动子的嘧啶调节以及对Dam甲基化修饰的干扰。在没有整合宿主因子的情况下以及在位于该Dam甲基化修饰位点上游约200 bp处的IHF位点发生突变的突变体中,这些过程也受到严重损害。因此,IHF至少部分地通过影响特定蛋白质 - DNA复合物的形成或稳定性,对P1发挥其拮抗作用,即在基本培养基中增加表达,但在存在嘧啶残基时增加抑制作用。此外,我们证明了分隔IHF和Dam甲基化靶位点的距离对于体内保护以及嘧啶介导的启动子表达调控至关重要。改变此距离的突变导致体内保护程度严重降低,并随之导致启动子P1活性的嘧啶残基抑制能力严重降低,其方式表明形成了复杂的核蛋白结构。由于IHF和CarP都不需要嘧啶残基来结合carAB控制区,至少在体外不需要,因此很诱人地推测,IHF和CarP诱导的弯曲和环化提供了DNA拓扑结构的变化,这是组装调节P1活性的特定嘧啶依赖性核蛋白复合物所必需的。